Evaluation of a Natural Experiment to Improve Statewide Depression Care in Minnesota (MN)
NCT00781703 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2631
Last updated 2014-07-15
Summary
The study will evaluate a unique natural experiment that aims to transform the primary care of patients with depression. The experiment's aim is to cause statewide implementation of an evidence-based care model for depression by changing the reimbursement system and by using an established regional collaborative (the Institute for Clinical Systems Improvement) to both facilitate the model's widespread use and certify that medical groups have implemented it. Study hypotheses include the following:
1. Newly treated depressed patients in medical groups that have implemented the new reimbursement and facilitation will report receiving higher rates of best care processes than such patients in these medical groups before implementation.
2. Rates of best care practices reported to be received by newly treated depressed patients two years after each medical group implements changes will be maintained at least at the rate reported by patients one year post implementation.
3. Newly treated depressed patients in medical groups that have participated in the new reimbursement and facilitation will have greater improvement in depression symptoms and work productivity and lower healthcare costs than such patients in groups before participation.
4. Medical group measures of priority for improving depression care, capability to manage change, and practice systems will be predictive of more patient-reported best care processes, both at one point in time and in change over time.
Conditions
Interventions
- OTHER
-
DIAMOND depression care model
Patients in activated clinic sites will receive the DIAMOND depression care model, including a care manager, frequent use of the PHQ9, treatment adjustment as indicated, psychiatric consultation, relapse prevention.
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH -
HealthPartners Institute
lead OTHER
Principal Investigators
-
Leif I Solberg, MD · HealthPartners Institute
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-02-29
- Primary Completion
- 2012-06-30
- Completion
- 2014-02-28
More Related Trials
-
DBS for Depression
NCT06096207 ·Status: RECRUITING ·Phase: PHASE1
-
Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis
NCT02330679 ·Status: UNKNOWN ·Phase: PHASE4
-
A Closed-loop Assessment and Treatment Platform for Unipolar Depression and Anxiety
NCT02948036 ·Status: COMPLETED ·Phase: NA
-
Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients
NCT06101914 ·Status: NOT_YET_RECRUITING
-
Mobile Technology to Engage and Link Patients and Providers in Antidepressant Treatment (MedLink)
NCT02583230 ·Status: COMPLETED ·Phase: NA
-
Eealy Improvement Predicts Antidepressants Response in Adults With Major Depression Disorder
NCT03230682 ·Status: UNKNOWN
-
Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults
NCT00183729 ·Status: COMPLETED ·Phase: PHASE4
-
Establish a Specific Cohort Database for Depressive Disorders
NCT05095662 ·Status: ACTIVE_NOT_RECRUITING
-
Precision Care for Major Depressive Disorder
NCT06580041 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Study to Evaluate the Safety and Efficacy of PEER Interactive to Inform Medication Prescription for Subjects With a Primary Diagnosis of Depression
NCT02988076 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
Optimization of Diagnosis and Treatment of Depression Based on Multidimensional Clinical Assessment Classification
NCT04528628 ·Status: UNKNOWN ·Phase: NA
-
Objective Diagnostic Markers and Personalized Intervention in MDD Patients
NCT02023567 ·Status: UNKNOWN ·Phase: NA
-
Stress Generation and Recurrent Depression: The Role of Differential Treatment Response
NCT00745017 ·Status: COMPLETED ·Phase: PHASE1
-
Multi-factor Model Constraction for Early Warning and Diagnosis of MDD
NCT05529576 ·Status: UNKNOWN ·Phase: PHASE4
-
Dichotic Listening as a Predictor of Medication Response in Depression
NCT00296725 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Predicting Response to Depression Treatment (PReDicT)
NCT02790970 ·Status: COMPLETED ·Phase: NA
-
Mechanistic Evaluation of Response in TRD (MERIT)
NCT04608396 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Infliximab for Treatment Resistant Major Depression
NCT00463580 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment Response Biomarkers in MDD
NCT05585047 ·Status: RECRUITING
-
Mobile Screening for Major Depressive Disorder in Adults From an Ethnically and Socioeconomically Diverse Population.
NCT05989412 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Organized Self-Management Support Services for Chronic Depression
NCT01139060 ·Status: COMPLETED ·Phase: PHASE3
-
Precision Medicine in the Depression Treatment
NCT05616559 ·Status: RECRUITING
-
Clinical and Neurobiological Profile Predictive of Pejorative Outcome of Depression
NCT03690856 ·Status: UNKNOWN ·Phase: NA
-
eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk
NCT04437485 ·Status: COMPLETED ·Phase: PHASE2
-
Depression Treatment in General Medical Settings
NCT00797901 ·Status: COMPLETED ·Phase: NA